Interaction of the mitochondria-targeted antioxidant MitoQ with phospholipid bilayers and ubiquinone oxidoreductases.
about
Antioxidants that protect mitochondria reduce interleukin-6 and oxidative stress, improve mitochondrial function, and reduce biochemical markers of organ dysfunction in a rat model of acute sepsisUnderstanding and preventing mitochondrial oxidative damageAn oxidative stress mechanism of shikonin in human glioma cellsComplementation of coenzyme Q-deficient yeast by coenzyme Q analogues requires the isoprenoid side chain.Neuroprotection by a mitochondria-targeted drug in a Parkinson's disease modelMitochondrial targeting of vitamin E succinate enhances its pro-apoptotic and anti-cancer activity via mitochondrial complex IIMitochondria-derived reactive oxygen species mediate caspase-dependent and -independent neuronal deaths.Oxidative metabolism enables Salmonella evasion of the NLRP3 inflammasome.The toxicity of tau in Alzheimer disease: turnover, targets and potential therapeuticsRedox signalling and cardioprotection: translatability and mechanismMitochondrial anti-oxidant protects IEX-1 deficient mice from organ damage during endotoxemia.The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer's disease.Antioxidant therapies for Alzheimer's diseaseDelivery of drugs and macromolecules to mitochondria.Collagen fragmentation promotes oxidative stress and elevates matrix metalloproteinase-1 in fibroblasts in aged human skin.Alpha-tocopheryl succinate induces apoptosis by targeting ubiquinone-binding sites in mitochondrial respiratory complex II.MitoQ, a mitochondria-targeted antioxidant, delays disease progression and alleviates pathogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.Mitochondria: a therapeutic target in neurodegenerationP-glycoprotein (Mdr1a/1b) and breast cancer resistance protein (Bcrp) decrease the uptake of hydrophobic alkyl triphenylphosphonium cations by the brain.Mitochondrial medicine for neurodegenerative diseases.Abnormal mitochondrial dynamics--a novel therapeutic target for Alzheimer's disease?Metabolic manipulators: a well founded strategy to combat mitochondrial dysfunction.Controlling subcellular delivery to optimize therapeutic effectMitochondrial dysfunction in nonalcoholic steatohepatitis.Inhibitors of succinate: quinone reductase/Complex II regulate production of mitochondrial reactive oxygen species and protect normal cells from ischemic damage but induce specific cancer cell death.Conflict of evidence: carotenoids and other micronutrients in the prevention and treatment of cognitive impairment.Perspectives and potential applications of mitochondria-targeted antioxidants in cardiometabolic diseases and type 2 diabetes.Protein S-nitrosylation in preconditioning and postconditioning.Strategy to reduce free radical species in Alzheimer's disease: an update of selected antioxidants.Mitochondrial Therapies in Heart Failure.A Powerful Mitochondria-Targeted Iron Chelator Affords High Photoprotection against Solar Ultraviolet A Radiation.Mitochondrial H2O2 generated from electron transport chain complex I stimulates muscle differentiation.The mitochondria-targeted antioxidant MitoQ modulates oxidative stress, inflammation and leukocyte-endothelium interactions in leukocytes isolated from type 2 diabetic patients.Targeting Mitochondrial Calcium Handling and Reactive Oxygen Species in Heart Failure.Mitochondria-targeted antioxidants protect pancreatic β-cells against oxidative stress and improve insulin secretion in glucotoxicity and glucolipotoxicity.Influence of an extremely low frequency magnetic field (ELF-EMF) on antioxidative vitamin E properties in AT478 murine squamous cell carcinoma culture in vitro.Mitochondria-targeted antioxidants do not prevent tumour necrosis factor-induced necrosis of L929 cells.A mitochondrial-targeted cyclosporin A with high binding affinity for cyclophilin D yields improved cytoprotection of cardiomyocytes.Protection against renal ischemia-reperfusion injury in vivo by the mitochondria targeted antioxidant MitoQSynthesis of triphenylphosphonium vitamin E derivatives as mitochondria-targeted antioxidants.
P2860
Q24622152-73E9F816-5DDC-4310-8040-141DEEACE738Q28080331-D903DCCB-B550-4E20-B97F-DDB88D14B754Q28537574-C647A3AC-7F1D-4F8B-96A8-D6544C90D10FQ33546630-77505C44-900C-41C7-B81E-5356B21F7F4AQ33608424-304983B9-01C6-4259-B2D4-953174BF927DQ34536966-E8D483D3-73C3-4025-90A5-FE31EDEDC817Q34603310-BE4D1CB0-D9AA-4069-A52D-6B2649EAE5E6Q35123268-5B4F35DD-3BA8-4E89-A70F-1290D0284FC2Q35216140-8534E330-2DF5-4F26-9C2A-AF5768FAE7FDQ35286322-857D40ED-0C65-46D9-9B72-6A41DFB6BC61Q35382736-1310287C-4689-4E49-9842-984002056BCEQ35908404-02F89268-6F84-4972-B6E8-B0834756134BQ36135040-9DF3F39F-38B3-4284-AABB-0CE887CF1C76Q36495454-AAA6D918-C621-45C1-BA49-8E2052DA2CF4Q37073774-28D3150B-FE68-4B3B-8BB0-8782F67413F4Q37158312-92F0BAF9-89AB-4043-BFD6-9AB45542930DQ37315208-47AA6AA1-97B8-4DAA-AE17-C3A47B4990A8Q37466059-33AB3551-5F95-474D-A405-DE28EDE51D66Q37504578-D1E1472A-7DE4-4843-AFC8-E16427AA8CCEQ37672741-6D3D0ECB-A7E2-4089-A132-DC470F128BFDQ37681370-BBA685CD-7480-4046-A3B0-DB12B5FEA4D1Q37776434-5EB16F4A-D0BA-457D-9130-1D81B7FDA2D3Q37813021-DED16193-856E-459C-BA67-4B49B981EA72Q37863137-91C3C69F-CA12-4E74-BDD4-7BE2F860A192Q37921677-499DEB9A-2FBE-4585-B873-20987D2D311EQ37993813-3E36CDA2-AE42-4526-A6E8-3E0DE68766B4Q38104693-AE7C2E54-7203-498F-BBD0-3A1B984888BAQ38199441-AE0968AA-08CE-4735-96EC-A17685465E96Q38253060-002226C8-BA2A-4E0B-BB04-2846C6E88323Q38759545-7424A86A-A88C-4FD0-84AD-7E31107E5354Q38775707-576B3D6B-7A10-41E8-B4DE-1A80D26F0843Q38857383-40D06AFA-F596-427D-AC61-BC7775DF96D9Q39218930-5C175B3C-45DF-453C-897D-4A147E553CE9Q39401767-1749CFEC-00D4-4197-A5C1-4B3ACEE4236EQ39426373-960A389F-84A7-4FB8-A1A9-E2EF7DA6043CQ39723323-8D88735C-423E-49EB-85F8-5F83DF0E4050Q40087541-F57E41B1-96EB-4E66-8474-F6F634E17DE8Q40478827-980091DB-1B22-42CF-922C-4C58F16B72C2Q40544872-2480C296-551F-4017-8ED9-C39C68902081Q41188746-A617EEEE-7A25-4C99-BA6A-71AEDAB9184E
P2860
Interaction of the mitochondria-targeted antioxidant MitoQ with phospholipid bilayers and ubiquinone oxidoreductases.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Interaction of the mitochondri ...... nd ubiquinone oxidoreductases.
@ast
Interaction of the mitochondri ...... nd ubiquinone oxidoreductases.
@en
Interaction of the mitochondri ...... nd ubiquinone oxidoreductases.
@nl
type
label
Interaction of the mitochondri ...... nd ubiquinone oxidoreductases.
@ast
Interaction of the mitochondri ...... nd ubiquinone oxidoreductases.
@en
Interaction of the mitochondri ...... nd ubiquinone oxidoreductases.
@nl
prefLabel
Interaction of the mitochondri ...... nd ubiquinone oxidoreductases.
@ast
Interaction of the mitochondri ...... nd ubiquinone oxidoreductases.
@en
Interaction of the mitochondri ...... nd ubiquinone oxidoreductases.
@nl
P2093
P356
P1476
Interaction of the mitochondri ...... nd ubiquinone oxidoreductases.
@en
P2093
Abdul-Rahman B Manas
Andrew M James
Frank E Frerman
Mark S Sharpley
Robin A J Smith
P304
14708-14718
P356
10.1074/JBC.M611463200
P407
P577
2007-03-16T00:00:00Z